NTx Expands Scientific Advisory Board with Appointment of RNA Biology Pioneer Dr. Jeff Coller
NTx, a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the appointment of Dr. Jeff Coller, Bloomberg Distinguished Professor of RNA Biology and Therapeutics at Johns Hopkins University, to its Scientific Advisory Board (SAB).
Excision BioTherapeutics Announces Positive Preclinical Data Highlighting the Safety, Potency and Development Progress of the Hepatitis B EBT-107 Program at the ICE-HBV “Hepatitis B Cure Symposium”
Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a biotechnology company developing CRISPR-based therapies to cure serious latent viral infectious diseases, today announced that positive preclinical data from its Hepatitis B virus (HBV) EBT-107 program were presented at the 6th ICE-HBV “HBV Cure Symposium” which took place on September 12, 2025, in Berlin, Germany.
Azumo and Cymmetrik Announce Strategic Global Partnership
Azumo, Inc., the leading developer of reflective display lightguide technologies, and Cymmetrik Group, a leading global provider of printing applications and value-added services, today announced a comprehensive strategic partnership that will redefine manufacturing for next-generation display and lighting applications across Industrial, Automotive, and Consumer Electronics markets.
Eaton and Xendee Collaborate to Optimize Microgrid Performance Using AI-Powered Tools for Greater Energy Savings, Security and Sustainability
Intelligent power management company Eaton is collaborating with Xendee Corporation, a provider of the leading design and operation platform for distributed energy and microgrid systems. Xendee’s cutting-edge microgrid modeling and operations platform combined with Eaton’s engineering expertise and proven power distribution technologies deliver a fully integrated microgrid solution. Eaton led a Series B financing round for Xendee Corporation to further accelerate the deployment of artificial intelligence (AI) powered tools for distributed energy resources (DERs), and to help power the next phase of Xendee’s growth. Together, the companies will provide customers a streamlined path to design, deploy and operate highly efficient, resilient microgrids and DERs.
CARB-X to support lower respiratory tract infection diagnostic by Zeteo
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) has awarded Zeteo Tech, Inc. US$1M to execute a workplan for its noninvasive diagnostic platform that aims to evaluate whether exhaled breath can diagnose lower respiratory tract infections (LRTIs) in high-risk populations within critical care environments, including intubated patients with mechanical ventilation.
EnCharge AI Receives Frost & Sullivan’s 2025 Global Technology Trailblazer Recognition for Advancing Analog AI Compute Innovation
Frost & Sullivan is pleased to announce that EnCharge AI has been awarded the 2025 Global Technology Trailblazer Recognition in the advanced analog AI chips sector for its outstanding achievements in innovation, strategy execution, and market disruption. This recognition acknowledges EnCharge AI’s leadership in delivering next-generation compute solutions and redefining AI deployment with transformative performance at the edge.
AM Batteries Launches First Interactive Savings Calculator to Quantify Cost and Performance Gains from Dry Electrode Manufacturing
AM Batteries (AMB), a pioneer in dry battery electrode (DBE) manufacturing technology, today announced the launch of its first interactive Savings Calculator, enabling battery makers to quickly quantify the financial and performance impact of adopting AMB’s Powder to Electrode™ dry-coating process.
BioSkryb Genomics Secures Exclusive License to Breakthrough Methylation Patent to Enable the First Single-Cell Five-Base Genome
BioSkryb Genomics, a pioneer in single-cell and ultra–low-input multi-omic solutions, today announced the execution of an exclusive license to a patent co-owned by Stanford University and the Chan Zuckerberg Biohub San Francisco (CZ Biohub SF) covering a method for combined single-cell DNA methylation and genome variation analyses. The invention originated at Stanford and enables simultaneous, high-resolution readouts of genomic variants and DNA methylation from the same single cell using a non-destructive workflow that preserves DNA integrity.
BioFlyte Awarded U.S. Department of Homeland Security SAFETY Act Designation for Qualified Anti-Terrorism Technology
BioFlyte, a chemical and bioaerosol surveillance firm with a disruptive new class of fieldable chemical and biological threat collection, detection, and identification solutions, today announced that the U.S. Department of Homeland Security (DHS) has awarded the company a SAFETY Act Designation for its aerosol chem/biothreat detection and identification technology. This recognition as a Qualified Anti-Terrorism Technology (QATT) underscores the proven effectiveness and reliability of BioFlyte’s solutions in detecting and mitigating airborne chemical and biological threats, while providing important liability protections under the Support Anti-terrorism by Fostering Effective Technologies (SAFETY) Act of 2002.
US Court Approved Anzu Partners Affiliate to acquire EnvisionTec, Leader in 3D Polymer Printers and Resins, Providing Financing and Stability for Operations
An affiliate of the US industrial technology investor Anzu Partners has been approved by a US court to acquire EnvisionTec GmbH (“EnvisionTec”), which provides customers, suppliers, and employees stability and consistency of operations going forward. Following the court’s approval, which had no objections and is not expected to be subject to any appeals, the parties will now begin implementing the transaction.